NEW YORK, Feb. 27, 2014 /PRNewswire/ -- Levi & Korsinsky is investigating Galena Biopharma, Inc. ("Galena Biopharma" or the "Company") (Nasdaq: GALE) for possible breaches of fiduciary duty. The investigation concerns whether a series of statements Galena Biopharma made regarding its business, prospects, and operations were materially false and misleading.
Click here to learn more about the investigation: http://zlk.9nl.com/galena-biopharma or call: 877-363-5972. There is no cost or obligation to you.
On February 14, 2014, Galena acknowledged that it had paid the investor relations firm The DreamTeam Group to promote the Company. The investigation concerns whether these promotional materials were misleading and/or omitted material information, and whether Company insiders took advantage of the positive press to sell significant amounts of shares for substantial profit.
If you own Gale Biopharma stock and wish to obtain additional information about the investigation and your legal rights, please contact Joseph E. Levi, Esq. either via email at firstname.lastname@example.org or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/galena-biopharma .Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm's 26 attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes. CONTACT: Levi & Korsinsky, LLP Joseph Levi, Esq. Eduard Korsinsky, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (866) 367-6510 www.zlk.com Logo - http://photos.prnewswire.com/prnh/20120409/MM84375LOGO SOURCE Levi & Korsinsky, LLP
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts